# Effects of Salmeterol on Autonomic Nervous System

> **NCT01536587** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 32 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Salmeterol

## Key facts

- **NCT ID:** NCT01536587
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01536587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01536587, "Effects of Salmeterol on Autonomic Nervous System". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01536587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*